4Suppliers
7Customers
1Debt Items
20Related Chains

Bio-Techne Corporation Suppliers

TickerNameConfidenceEvidence
TMO Thermo Fisher Scientific Inc. 90% we sell through a distribution agreement with Thermo Fisher Scientific
TMO Thermo Fisher Scientific Inc. 90% Reciprocal relationship from TMO graph: Reciprocal relationship from TECH graph: Reciprocal relationship from TMO graph: Reciprocal relationship from TECH graph: we sell through a distribution agreem…
ONCO Onconetix, Inc. 72% Reciprocal relationship from ONCO graph: Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and…
XNCR Xencor, Inc. 72% Reciprocal relationship from XNCR graph: old 8,093,712 shares of our common stock at the public offering price of $18.00 per share, which included the exercise in full by the underwriters of their op…

Bio-Techne Corporation Customers

TickerNameConfidenceEvidence
ACADEMIC-CUSTOMERS ACADEMIC-CUSTOMERS 92% Segment growth was driven by growth in consumable revenue to BioPharma (especially those developing cell and gene therapies) and Academic customers within the Americas and Europe
BIOPHARMA BIOPHARMA 92% Segment growth was driven by growth in consumable revenue to BioPharma (especially those developing cell and gene therapies)
ONCO Onconetix, Inc. 72% Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and gre…
ACQUISITIONS-NAMOCELL-INC ACQUISITIONS-NAMOCELL-INC 62% . Amortization expense related to customer relationships is reflected in 67 Table of Contents selling, general and administrative expenses in the Consolidated Statement of Earnings and Comprehensive …
CHANGZHOU-EMINENCE-BIOTECHNOLOGY-CO-LTD CHANGZHOU-EMINENCE-BIOTECHNOLOGY-CO-LTD 62% excluding revenue from acquisitions within the preceding 12 months, the impact of foreign currency, the impact of businesses held-for-sale, as well as the impact of partially-owned consolidated subsi…
EQUITY-BIO-TECHNE-CORPORATION EQUITY-BIO-TECHNE-CORPORATION 62% excluding revenue from acquisitions within the preceding 12 months, the impact of foreign currency, the impact of businesses held-for-sale, as well as the impact of partially-owned consolidated subsi…
LUNAPHORE-TECHNOLOGIES LUNAPHORE-TECHNOLOGIES 62% of Contents Note 4 . Acquisitions: We periodically complete business combinations that align with our business strategy. Acquisitions are accounted for using the acquisition method of accounting, whi…

Bio-Techne Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
TECH-DEBT Debt stack $290.3M 90% Market cache reports total debt of $290.3M.

Bio-Techne Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bio-Techne Corporation.

Bio-Techne Corporation Ownership

HolderNameConfidenceEvidence
TECH-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 586 tracked holders.

Bio-Techne Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
XNCR Xencor, Inc. 100.00 1 ['supplier']
TMO Thermo Fisher Scientific Inc. 100.00 1 ['supplier']
ONCO Onconetix, Inc. 100.00 1 ['customer', 'supplier']
RGEN Repligen Corporation 50.00 2
VNRX VolitionRx Limited 50.00 2
ABT Abbott Laboratories 50.00 2
BHPLF BHP Group Limited 50.00 2
CLLS Cellectis S.A. 50.00 2
VIR Vir Biotechnology, Inc. 50.00 2
GILD Gilead Sciences, Inc. 50.00 2
ICLR ICON Public Limited Company 50.00 2
WAT Waters Corporation 50.00 2
DNA Ginkgo Bioworks Holdings, Inc. 50.00 2
GH Guardant Health, Inc. 50.00 2
IDXG Interpace Biosciences, Inc. 50.00 2
IMTX Immatics N.V. 50.00 2
HRMY Harmony Biosciences Holdings, Inc. 50.00 2
HUMA Humacyte, Inc. 50.00 2
AZTA Azenta, Inc. 50.00 2
TWST Twist Bioscience Corporation 50.00 2